Coronavirus Update: Will Dexamethasone Breakthrough Make Remdesivir Irrelevant?

Plus AZ's Vaccine May Only Protect For One Year

 
• By Scrip Team
  
Old Road Campus
The University of Oxford, which is leading the multi-arm RECOVERY trial

More from COVID-19

More from Scrip